S. 2103
Referred to CommitteeAffordable Insulin Approvals Now Act
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
7/11/2019 • Senate
Summary
Affordable Insulin Approvals Now Act
This bill requires the continued review and approval, as appropriate, of certain pending applications for generic insulin beyond the March 23, 2020, cutoff date previously established by the Food and Drug Administration. Beginning March 23, 2020, these approved generic insulin drugs also are deemed licensed biological products.
Introduced in Senate • 7/11/2019
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (17)
Party Breakdown
Sponsor
Cosponsors (16)
Bill Journey
Originated in the Senate
Introduced
July 11, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law